U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 1122

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:155150555-176854100
GRCh38:
Chr2:154294042-175989372
SLC25A12, SLC38A11, SPC25, SLC4A10, SNORA70F, SNORD3K, SP3, SP5, SP9, SSB, STK39, TANC1, TANK, TANK-AS1, TBR1, TLK1, TRA-CGC3-1, TRG-GCC2-2, TTC21B, TTC21B-AS1, UBR3, UPP2, WDSUB1, WIPF1, XIRP2, XIRP2-AS1, ABCB11, ACVR1, ACVR1C, ATF2, ATP5MC3, B3GALT1, B3GALT1-AS1, BAZ2B, BAZ2B-AS1, BBS5, CCDC148, CCDC148-AS1, CD302, CDCA7, CERS6, CERS6-AS1, CFAP210, CHN1, CHRNA1, CIR1, COBLL1, CSRNP3, CYBRD1, CYTIP, DAPL1, DCAF17, DHRS9, DLX1, DLX2, DLX2-DT, DPP4, DPP4-DT, DYNC1I2, ERICH2, ERICH2-DT, ERMN, FAP, FASTKD1, FIGN, FLJ46875, G6PC2, GAD1, GALNT13, GALNT13-AS1, GALNT3, GALNT5, GCA, GCG, GORASP2, GPD2, GPR155, GPR155-DT, GRB14, HAT1, IFIH1, ITGA6, ITGA6-AS1, ITGB6, KCNH7, KCNH7-AS1, KCNJ3, KLHL23, KLHL41, LINC01124, LINC01305, LINC01806, LINC01876, LINC01960, LINC02478, LNPK, LOC100506124, LOC101929532, LOC101929633, LOC102724058, LOC108175345, LOC108281133, LOC110120601, LOC110120624, LOC110120625, LOC110120626, LOC110120673, LOC110120674, LOC110120675, LOC110120676, LOC110120677, LOC110120678, LOC110120701, LOC110120708, LOC110120710, LOC110120725, LOC110120730, LOC110120736, LOC110120790, LOC110120809, LOC110121120, LOC110121216, LOC110121242, LOC111413009, LOC111556122, LOC112806056, LOC112806057, LOC112806058, LOC112806059, LOC112806060, LOC114827830, LOC115945201, LOC117152610, LOC117152611, LOC120977010, LOC120977011, LOC120977012, LOC120977013, LOC120977014, LOC120977015, LOC121725105, LOC121725106, LOC121725107, LOC122847298, LOC122847299, LOC122847300, LOC122847301, LOC122847302, LOC122847303, LOC122847304, LOC122847305, LOC122847306, LOC122847307, LOC122847308, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC122847317, LOC122847318, LOC122847319, LOC122847320, LOC122861240, LOC122861241, LOC122861242, LOC122861243, LOC122861244, LOC122861245, LOC122861246, LOC126806382, LOC126806383, LOC126806384, LOC126806385, LOC126806386, LOC126806387, LOC126806388, LOC126806389, LOC126806390, LOC126806391, LOC126806392, LOC126806393, LOC126806394, LOC126806395, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LOC126806404, LOC126806405, LOC126806406, LOC126806407, LOC126806408, LOC126806409, LOC126806410, LOC126806411, LOC126806412, LRP2, LY75, LY75-CD302, MAP3K20, MAP3K20-AS1, MARCHF7, METAP1D, METTL5, METTL8, MIR4774, MIR4785, MIR6888, MIR933, MYO3B, MYO3B-AS1, NOSTRIN, NR4A2, OLA1, PDK1, PHOSPHO2, PHOSPHO2-KLHL23, PKP4, PKP4-AS1, PLA2R1, PPIG, PSMD14, PSMD14-DT, RAPGEF4, RAPGEF4-AS1, RBMS1, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SCRN3
See casesPathogenic
(Mar 10, 2014)
no assertion criteria provided
2.
GRCh37:
Chr2:164821892-183059789
GRCh38:
Chr2:163965382-182195062
ABCB11, AGPS, ATF2, ATP5MC3, B3GALT1, B3GALT1-AS1, BBS5, CCDC141, CDCA7, CERKL, CERS6, CERS6-AS1, CFAP210, CHN1, CHRNA1, CHROMR, CIR1, COBLL1, CSRNP3, CWC22, CYBRD1, DCAF17, DHRS9, DLX1, DLX2, DLX2-DT, DYNC1I2, EPCART, ERICH2, ERICH2-DT, EVX2, FASTKD1, FKBP7, G6PC2, GAD1, GALNT3, GORASP2, GPR155, GPR155-DT, GRB14, HAGLR, HAGLROS, HAT1, HNRNPA3, HOXD-AS2, HOXD1, HOXD10, HOXD11, HOXD12, HOXD13, HOXD3, HOXD4, HOXD8, HOXD9, IFT70A, IFT70B, ITGA4, ITGA6, ITGA6-AS1, ITPRID2, KLHL23, KLHL41, LINC01116, LINC01117, LINC01124, LINC01305, LINC01934, LINC01960, LNPK, LOC100130691, LOC100506124, LOC101927055, LOC101929633, LOC102724058, LOC105373759, LOC107126359, LOC108281145, LOC110120624, LOC110120625, LOC110120626, LOC110120627, LOC110120628, LOC110120677, LOC110120678, LOC110120701, LOC110120730, LOC110120790, LOC110120809, LOC110121216, LOC111413009, LOC112806057, LOC112806058, LOC112806059, LOC112806060, LOC112806061, LOC112806062, LOC112806063, LOC115945201, LOC120977013, LOC120977014, LOC120977015, LOC120977016, LOC121725107, LOC122847308, LOC122847309, LOC122847310, LOC122847311, LOC122847312, LOC122847313, LOC122847314, LOC122847315, LOC122847316, LOC122847317, LOC122847318, LOC122847319, LOC122847320, LOC122861240, LOC122861241, LOC122861242, LOC122861243, LOC122861244, LOC122861245, LOC122861246, LOC122861247, LOC122861248, LOC122861249, LOC122861250, LOC122861251, LOC122861252, LOC122861253, LOC122861254, LOC122861255, LOC122861256, LOC122861257, LOC122861258, LOC122861259, LOC122861260, LOC122861261, LOC122861262, LOC126806396, LOC126806397, LOC126806398, LOC126806399, LOC126806400, LOC126806401, LOC126806402, LOC126806403, LOC126806404, LOC126806405, LOC126806406, LOC126806407, LOC126806408, LOC126806409, LOC126806410, LOC126806411, LOC126806412, LOC126806413, LOC126806414, LOC126806415, LOC126806416, LOC126806417, LOC126806418, LOC126806419, LOC126806420, LOC126806421, LOC126806422, LOC126806423, LOC126806424, LOC126806425, LOC126806426, LOC126806427, LOC126806428, LOC126806429, LOC126806430, LOC126806431, LOC126806432, LOC126806433, LOC126806434, LOC126806435, LOC126806436, LOC126806437, LOC126806438, LOC126806439, LOC126806440, LOC126806441, LOC401021, LRP2, MAP3K20, MAP3K20-AS1, METAP1D, METTL5, METTL8, MIR10B, MIR1246, MIR1258, MIR3128, MIR4437, MIR4444-1, MIR4774, MIR6512, MIR7704, MIR933, MTX2, MYO3B, MYO3B-AS1, NEUROD1, NFE2L2, NOSTRIN, OLA1, OSBPL6, PDE11A, PDE11A-AS1, PDE1A, PDK1, PHOSPHO2, PHOSPHO2-KLHL23, PJVK, PLEKHA3, PPIG, PPP1R1C, PRKRA, RAPGEF4, RAPGEF4-AS1, RBM45, SCHLAP1, SCN1A, SCN1A-AS1, SCN2A, SCN3A, SCN7A, SCN9A, SCRN3, SESTD1, SLC25A12, SLC38A11, SNORA70F, SNORD3K, SP3, SP5, SP9, SPC25, SSB, STK39, TLK1, TTC21B, TTC21B-AS1, TTN, TTN-AS1, UBE2E3, UBE2E3-DT, UBR3, WIPF1, XIRP2, XIRP2-AS1, ZNF385B
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
3.
GRCh37:
Chr2:164922548-172962614
GRCh38:
Chr2:164066038-172097886
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh37:
Chr2:165706627-176423918
GRCh38:
Chr2:164850117-175559190
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
5.
GRCh37:
Chr2:169740860-170815789
GRCh38:
Chr2:168884350-169959279
See casesUncertain significance
(Oct 24, 2012)
no assertion criteria provided
6.
GRCh37:
Chr2:169779462
GRCh38:
Chr2:168922952
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr2:169779492
GRCh38:
Chr2:168922982
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr2:169779599
GRCh38:
Chr2:168923089
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr2:169779623
GRCh38:
Chr2:168923113
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr2:169779692
GRCh38:
Chr2:168923182
ABCB11Progressive familial intrahepatic cholestasis type 2Likely benign
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr2:169779712
GRCh38:
Chr2:168923202
ABCB11Progressive familial intrahepatic cholestasis type 2Benign
(Jan 13, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr2:169779726
GRCh38:
Chr2:168923216
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr2:169779764
GRCh38:
Chr2:168923254
ABCB11Progressive familial intrahepatic cholestasis type 2Benign
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr2:169779816
GRCh38:
Chr2:168923306
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr2:169779851
GRCh38:
Chr2:168923341
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr2:169779880
GRCh38:
Chr2:168923370
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr2:169779895
GRCh38:
Chr2:168923385
ABCB11Progressive familial intrahepatic cholestasis type 2Likely benign
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr2:169779896
GRCh38:
Chr2:168923386
ABCB11not provided, Progressive familial intrahepatic cholestasis type 2Benign
(Jun 29, 2018)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr2:169779939
GRCh38:
Chr2:168923429
ABCB11Progressive familial intrahepatic cholestasisUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
20.
GRCh37:
Chr2:169780106
GRCh38:
Chr2:168923596
ABCB11Progressive familial intrahepatic cholestasis type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr2:169780126
GRCh38:
Chr2:168923616
ABCB11not specifiedLikely benign
(Feb 10, 2016)
criteria provided, single submitter
22.
GRCh37:
Chr2:169780136
GRCh38:
Chr2:168923626
ABCB11S1321Tnot providedUncertain significance
(Mar 9, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr2:169780136
GRCh38:
Chr2:168923626
ABCB11S1321Nnot provided, Progressive familial intrahepatic cholestasis type 2Conflicting interpretations of pathogenicity
(Aug 6, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr2:169780141
GRCh38:
Chr2:168923631
ABCB11not providedLikely benign
(Jul 22, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr2:169780147
GRCh38:
Chr2:168923637
ABCB11not providedLikely benign
(Feb 18, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr2:169780152
GRCh38:
Chr2:168923642
ABCB11T1316AProgressive familial intrahepatic cholestasis type 2Uncertain significance
(Aug 13, 2020)
no assertion criteria provided
27.
GRCh37:
Chr2:169780153
GRCh38:
Chr2:168923643
ABCB11T1316fsnot providedUncertain significance
(Feb 25, 2016)
criteria provided, single submitter
28.
GRCh37:
Chr2:169780161
GRCh38:
Chr2:168923651
ABCB11not providedLikely benign
(May 29, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr2:169780171
GRCh38:
Chr2:168923661
ABCB11not providedLikely benign
(Aug 29, 2020)
criteria provided, single submitter
30.
GRCh37:
Chr2:169780175
GRCh38:
Chr2:168923665
ABCB11G1308fsnot providedUncertain significance
(Oct 24, 2017)
criteria provided, single submitter
31.
GRCh37:
Chr2:169780177
GRCh38:
Chr2:168923667
ABCB11not providedLikely benign
(May 27, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr2:169780181
GRCh38:
Chr2:168923671
ABCB11Q1306Rnot providedLikely benign
(Mar 18, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr2:169780183
GRCh38:
Chr2:168923673
ABCB11not providedLikely benign
(Oct 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr2:169780192
GRCh38:
Chr2:168923682
ABCB11not providedLikely benign
(Sep 26, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr2:169780194
GRCh38:
Chr2:168923684
ABCB11E1302*not providedPathogenic
(Jul 28, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr2:169780195
GRCh38:
Chr2:168923685
ABCB11not providedLikely benign
(Feb 22, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr2:169780204
GRCh38:
Chr2:168923694
ABCB11not providedLikely benign
(Oct 24, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr2:169780207-169780208
GRCh38:
Chr2:168923697-168923698
ABCB11T1299fsnot providedPathogenic
(Mar 26, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr2:169780223
GRCh38:
Chr2:168923713
ABCB11G1292EBenign recurrent intrahepatic cholestasis type 2Likely pathogenic
(Sep 18, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr2:169780223
GRCh38:
Chr2:168923713
ABCB11G1292Vnot providedUncertain significance
(Oct 24, 2016)
criteria provided, single submitter
41.
GRCh37:
Chr2:169780234
GRCh38:
Chr2:168923724
ABCB11not providedLikely benign
(May 13, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr2:169780244
GRCh38:
Chr2:168923734
ABCB11I1285Nnot providedUncertain significance
(Jul 20, 2017)
criteria provided, single submitter
43.
GRCh37:
Chr2:169780249
GRCh38:
Chr2:168923739
ABCB11not providedLikely benign
(Oct 31, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr2:169780250
GRCh38:
Chr2:168923740
ABCB11A1283Vnot provided, Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2
Uncertain significance
(May 7, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr2:169780252
GRCh38:
Chr2:168923742
ABCB11not providedLikely benign
(Oct 3, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr2:169780258
GRCh38:
Chr2:168923748
ABCB11not providedLikely benign
(Jan 11, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr2:169780264
GRCh38:
Chr2:168923754
ABCB11not providedLikely benign
(Apr 14, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr2:169780264
GRCh38:
Chr2:168923754
ABCB11not specifiedUncertain significance
(Jun 27, 2016)
criteria provided, single submitter
49.
GRCh37:
Chr2:169780270
GRCh38:
Chr2:168923760
ABCB11not providedLikely benign
(Jun 23, 2020)
criteria provided, single submitter
50.
GRCh37:
Chr2:169780281
GRCh38:
Chr2:168923771
ABCB11I1273Vnot providedUncertain significance
(Nov 16, 2016)
criteria provided, single submitter
51.
GRCh37:
Chr2:169780286
GRCh38:
Chr2:168923776
ABCB11I1271NProgressive familial intrahepatic cholestasis type 2Likely pathogenicno assertion criteria provided
52.
GRCh37:
Chr2:169780288
GRCh38:
Chr2:168923778
ABCB11not providedLikely benign
(Jan 19, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr2:169780292
GRCh38:
Chr2:168923782
ABCB11T1269IProgressive familial intrahepatic cholestasisUncertain significance
(Feb 28, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr2:169780294
GRCh38:
Chr2:168923784
ABCB11not providedLikely benign
(Mar 18, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr2:169780294
GRCh38:
Chr2:168923784
ABCB11T1269fsnot providedPathogenic
(Aug 19, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr2:169780296
GRCh38:
Chr2:168923786
ABCB11not providedLikely benign
(Nov 11, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr2:169780296
GRCh38:
Chr2:168923786
ABCB11R1268Wnot providedPathogenic
(Oct 21, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr2:169780300
GRCh38:
Chr2:168923790
ABCB11not providedLikely benign
(Jul 22, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr2:169780311
GRCh38:
Chr2:168923801
ABCB11K1263*not providedPathogenic
(Apr 25, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr2:169780312
GRCh38:
Chr2:168923802
ABCB11not providedLikely benign
(May 21, 2019)
criteria provided, single submitter
61.
GRCh37:
Chr2:169780316
GRCh38:
Chr2:168923806
ABCB11L1261Pnot providedUncertain significance
(Jan 9, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr2:169780320
GRCh38:
Chr2:168923810
ABCB11A1260Pnot providedUncertain significance
(Nov 28, 2016)
criteria provided, single submitter
63.
GRCh37:
Chr2:169780323
GRCh38:
Chr2:168923813
ABCB11V1259Inot providedLikely benign
(Aug 22, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr2:169780326
GRCh38:
Chr2:168923816
ABCB11Q1258*not providedPathogenic
(Jul 14, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr2:169780327
GRCh38:
Chr2:168923817
ABCB11not providedLikely benign
(Sep 8, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr2:169780330
GRCh38:
Chr2:168923820
ABCB11not specified, not providedConflicting interpretations of pathogenicity
(Dec 21, 2017)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr2:169780330-169780331
GRCh38:
Chr2:168923820-168923821
ABCB11V1257fsnot providedPathogenic
(Mar 15, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr2:169780331
GRCh38:
Chr2:168923821
ABCB11T1256Rnot providedUncertain significance
(May 2, 2016)
criteria provided, single submitter
69.
GRCh37:
Chr2:169780336
GRCh38:
Chr2:168923826
ABCB11not providedLikely benign
(Aug 16, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr2:169780342
GRCh38:
Chr2:168923832
ABCB11not providedConflicting interpretations of pathogenicity
(Oct 16, 2022)
criteria provided, conflicting interpretations
71.
GRCh37:
Chr2:169780366
GRCh38:
Chr2:168923856
ABCB11not provided, Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2
Benign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr2:169780885
GRCh38:
Chr2:168924375
ABCB11not providedBenign
(Nov 10, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr2:169780961
GRCh38:
Chr2:168924451
ABCB11not providedBenign
(Nov 10, 2018)
criteria provided, single submitter
74.
GRCh37:
Chr2:169781159
GRCh38:
Chr2:168924649
ABCB11not providedLikely benign
(Feb 18, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr2:169781197
GRCh38:
Chr2:168924687
ABCB11not providedLikely benign
(Feb 17, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr2:169781200
GRCh38:
Chr2:168924690
ABCB11not providedLikely benign
(Jun 28, 2020)
criteria provided, single submitter
77.
GRCh37:
Chr2:169781204
GRCh38:
Chr2:168924694
ABCB11D1243GProgressive familial intrahepatic cholestasis type 2Uncertain significancecriteria provided, single submitter
78.
GRCh37:
Chr2:169781209
GRCh38:
Chr2:168924699
ABCB11not providedLikely benign
(Dec 7, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr2:169781210
GRCh38:
Chr2:168924700
ABCB11L1241Pnot providedLikely pathogenic
(Jan 1, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr2:169781226
GRCh38:
Chr2:168924716
ABCB11D1236Ynot providedUncertain significance
(Aug 10, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr2:169781229
GRCh38:
Chr2:168924719
ABCB11R1235*not providedPathogenic
(Aug 28, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr2:169781240
GRCh38:
Chr2:168924730
ABCB11R1231Qnot providedPathogenic
(Sep 15, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr2:169781241
GRCh38:
Chr2:168924731
ABCB11R1231Wnot provided, Familial intrahepatic cholestasis type 2Pathogenic/Likely pathogenic
(May 14, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr2:169781245
GRCh38:
Chr2:168924735
ABCB11I1229MProgressive familial intrahepatic cholestasis type 2Uncertain significance
(Dec 26, 2019)
criteria provided, single submitter
85.
GRCh37:
Chr2:169781248
GRCh38:
Chr2:168924738
ABCB11not providedLikely benign
(Aug 31, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr2:169781255
GRCh38:
Chr2:168924745
ABCB11R1226LCholestasis, intrahepatic, of pregnancy, 3Likely pathogenicno assertion criteria provided
87.
GRCh37:
Chr2:169781256
GRCh38:
Chr2:168924746
ABCB11R1226Cnot providedUncertain significance
(Jul 9, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr2:169781263
GRCh38:
Chr2:168924753
ABCB11not providedLikely benign
(Nov 2, 2020)
criteria provided, single submitter
89.
GRCh37:
Chr2:169781263
GRCh38:
Chr2:168924753
ABCB11E1223DCholestasis, intrahepatic, of pregnancy, 3Pathogenicno assertion criteria provided
90.
GRCh37:
Chr2:169781270
GRCh38:
Chr2:168924760
ABCB11R1221KProgressive familial intrahepatic cholestasis type 2Pathogenicno assertion criteria provided
91.
GRCh37:
Chr2:169781272-169781273
GRCh38:
Chr2:168924762-168924763
ABCB11not providedPathogenic
(Feb 5, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr2:169781285
GRCh38:
Chr2:168924775
ABCB11G1216Anot providedUncertain significance
(Jun 6, 2016)
criteria provided, single submitter
93.
GRCh37:
Chr2:169781296
GRCh38:
Chr2:168924786
ABCB11S1214fsnot providedPathogenic
(Jul 3, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr2:169781298
GRCh38:
Chr2:168924788
ABCB11V1212Inot providedUncertain significance
(Mar 21, 2018)
criteria provided, single submitter
95.
GRCh37:
Chr2:169781299
GRCh38:
Chr2:168924789
ABCB11Progressive familial intrahepatic cholestasis type 2, not providedConflicting interpretations of pathogenicity
(Jun 22, 2022)
criteria provided, conflicting interpretations
96.
GRCh37:
Chr2:169781301
GRCh38:
Chr2:168924791
ABCB11N1211Dnot providedLikely benign
(Jun 9, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr2:169781303
GRCh38:
Chr2:168924793
ABCB11T1210Snot providedConflicting interpretations of pathogenicity
(Jun 23, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr2:169781304
GRCh38:
Chr2:168924794
ABCB11T1210Pnot providedLikely pathogenic
(Sep 13, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr2:169781308
GRCh38:
Chr2:168924798
ABCB11not providedLikely benign
(Aug 17, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr2:169781316-169781317
GRCh38:
Chr2:168924806-168924807
ABCB11not providedBenign
(Mar 29, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination